Status:
COMPLETED
Aerosol Cyclosporine for Prevention of Lung Rejection
Lead Sponsor:
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
Lung Diseases
Eligibility:
All Genders
Up to 100 years
Phase:
PHASE2
Brief Summary
To evaluate the efficacy of aerosolized cyclosporine given in addition to the standard oral immunosuppressive drug regimen, in preventing acute rejection immediately after lung transplantation
Detailed Description
BACKGROUND: Success with lung transplantation has largely been due to the introduction of cyclosporine which has proved effective in controlling lung allograft rejection. Nevertheless, acute and chro...
Eligibility Criteria
Inclusion
- No eligibility criteria
Exclusion
Key Trial Info
Start Date :
April 1 1998
Trial Type :
INTERVENTIONAL
End Date :
March 1 2003
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00268515
Start Date
April 1 1998
End Date
March 1 2003
Last Update
May 13 2016
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.